Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
Clinical trial NCT00443872 · COMPLETED
Trial details
- NCT number
- NCT00443872
- Sponsor
- Parkinson's Disease and Movement Disorder Center of Boca Raton
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-09-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.